Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Vir Biotechnology, Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Vir Biotechnology appointed Timothy Coughlin, CPA, to its Board of Directors on June 9, 2026, expanding the board from seven to eight members. Coughlin was also named Chair of the Audit Committee, strengthening the company's financial governance and oversight capabilities.
Key Takeaways
Timothy Coughlin, CPA, appointed as new Class III director, serving until the 2028 annual stockholder meeting
Board size expanded from seven to eight members to accommodate the new appointment
2 more takeaways